Skip to main content
BAXTER INTERNATIONAL INC logo

BAXTER INTERNATIONAL INC — Investor Relations & Filings

Ticker · BAX ISIN · US0718131099 LEI · J5OIVXX3P24RJRW5CK77 US Manufacturing
Open in API
Filings indexed 2,456 across all filing types
Latest filing 2021-12-13 Capital/Financing Update
Country US United States of America
Listing US BAX

About BAXTER INTERNATIONAL INC

https://www.baxter.com/

Baxter International Inc. is a global healthcare company focused on saving and sustaining lives. The company provides a broad portfolio of essential products across renal care, hospital, and surgical settings. Key offerings include technologies for acute and chronic dialysis, sterile intravenous (IV) solutions, infusion systems, clinical nutrition, and critical care. Baxter develops, manufactures, and markets a range of medical devices, connected care solutions, and advanced injectable pharmaceuticals. The company's products are used by healthcare professionals in hospitals, clinics, and homes to provide smarter, more personalized care for patients.

Recent filings

Filing Released Lang Actions
S-8
Capital/Financing Update Classification · 95% confidence The document is a Form S-8 Registration Statement filed with the SEC by Baxter International Inc. It registers shares of common stock issuable pursuant to a stock incentive plan following a merger. The document includes detailed legal and regulatory disclosures, incorporation by reference of other filings, indemnification provisions, and exhibits. It is a registration statement for securities under the Securities Act of 1933, not a financial report, earnings release, or management discussion. It is a capital markets filing related to share registration for employee stock plans, which fits the category of Capital/Financing Update (CAP). The document is lengthy (15,000 characters) and contains substantive information about the registration of securities, not just an announcement or certification. Therefore, the appropriate classification is CAP with high confidence.
2021-12-13 English
FORM 4 SUBMISSION
Director's Dealing
2021-12-07 English
8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content details the entry into a material definitive agreement related to the issuance of senior notes (debt financing) by Baxter International Inc. It includes detailed terms of the notes, interest rates, maturities, redemption options, covenants, and registration rights. This is a clear update on the company's capital and financing activities, specifically the issuance of new debt instruments to fund a merger and refinance existing debt. The document is not an annual or quarterly report, nor is it a transcript, proxy, or governance document. It is not a simple announcement of a report publication but a substantive disclosure of financing transactions. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length (15,000 characters) and detailed financial terms support this classification with high confidence.
2021-12-02 English
8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated November 29, 2021, reporting the appointment of a new Executive Vice President and Chief Operating Officer at Baxter International Inc. It details the individual's background, compensation terms, and includes an offer letter as an exhibit. The key content is about a change in senior management. There are no financial statements or earnings data presented, nor is this a report or announcement of financial results. The document fits the category of announcements related to changes in the company's board or senior management.
2021-11-30 English
8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated November 16, 2021, by Baxter International Inc. It announces the entry into a material definitive agreement related to the sale of various senior notes (debt securities) totaling several billion dollars. The document details the terms of the purchase agreement for these notes, including interest rates, maturity dates, and the private placement nature of the offering. There are no financial statements or detailed financial performance data included, only the announcement of the financing transaction. This fits the definition of a Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities. The document length is about 5993 characters, sufficient to contain substantive information about the financing but not a full financial report. Therefore, the correct classification is CAP with high confidence.
2021-11-17 English
8-K
M&A Activity Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC by Baxter International Inc. It announces a definitive merger agreement with Hill-Rom Holdings, Inc., including details about the merger consideration and expected closing timeline. The document includes forward-looking statements and risk factors related to the merger. It also references unaudited pro forma condensed combined financial statements as an exhibit but does not contain the full financial statements or detailed financial analysis itself. The document is primarily an announcement of a significant corporate event (merger agreement) and related disclosures, typical of a merger-related filing. It is not a full annual or quarterly report, audit report, earnings release, or other detailed financial report. The best fitting category is M&A Activity (TAR) as it relates to merger announcements and related documents.
2021-11-15 English

Browse filings by year

33 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.